Saturday 17 October 2026
Export CHSCP’s income statement to Excel — free account
CHS Inc
CHSCP Consumer Defensive Farm Products
CHS Inc’s revenue for fiscal 2025 (year ended August 2025) was $35.5 billion, down 9.68% from fiscal 2024. In the quarter to May 2026, revenue grew 18.6%, free cash flow grew 215.9% and total debt rose 5.82%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
25.78
0.14
−0.54%
Follow CHSCP
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.04 | 0.04 | 0.05 | 0.04 | |
EV/EBITDA |
2.03 | 1.94 | 2.71 | 2.21 | |
EV/Operating CF |
2.37 | 2.46 | 1.78 | 1.11 | |
EV/FCF |
(4.57) | (4.97) | 7.14 | 1.80 | |
Quick Ratio |
0.76 | 0.63 | 0.54 | 0.74 | |
Current Ratio |
1.53 | 1.42 | 1.45 | 1.47 | |
Net Debt/EBITDA |
6.20 | 4.98 | (27.24) | 5.98 | |
Debt/Assets |
9.73% | 8.82% | 10.20% | 10.27% | |
Debt/Equity |
0.17 | 0.16 | 0.19 | 0.19 | |
Asset Turnover |
1.89 | 1.74 | 1.74 | 1.85 | |
Operating CF/Net income |
6.46 | (1.30) | 3.87 | 4.14 | |
Capex/Depreciation |
(0.91) | (0.68) | (0.64) | (1.00) | |
Interest Coverage |
1.10 | 3.25 | (5.53) | 2.18 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.21% | 3.02% | 3.20% | 2.61% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
1,098.50 | (453.33) | (679.84) | 943.53 | |
Working Capital |
2,803.87 | 2,931.83 | 3,174.51 | 3,171.97 | |
Capital Expenditures |
(172.56) | (115.51) | (110.82) | (164.52) | |
Net Current Asset Value |
302.68 | 363.53 | 407.71 | 371.01 | |
EV/EBIT |
16.62 | 19.62 | 435.74 | 39.23 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3,618.25 | 3,864.73 | 3,497.98 | 4,370.02 | |
Average Payables |
2,707.47 | 3,568.20 | 2,717.08 | 2,885.15 | |
Average Inventory |
3,168.88 | 4,114.44 | 4,765.53 | 3,528.83 | |
Average Assets |
18,789.46 | 20,159.85 | 20,503.95 | 20,232.27 | |
Average Common Equity |
8,657.01 | 8,748.57 | 8,623.17 | 8,732.88 |
Columns are period end dates